Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 203,962Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Uptravi

PharmaCompass

01

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 1,093

2019 Revenue in Millions : 819

Growth (%) : 33

blank

02

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 1,237

2020 Revenue in Millions : 1,093

Growth (%) : 13

blank

03

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 1,322

2021 Revenue in Millions : 1,237

Growth (%) : 7

blank

04

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 1,582

2022 Revenue in Millions : 1,322

Growth (%) : 20

blank

05

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 243

2015 Revenue in Millions : Not Reported

Growth (%) : New Launch

blank

06

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 263

2016 Revenue in Millions : 259

Growth (%) : 2

blank

07

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 663

2017 Revenue in Millions : 263

Growth (%) : 152%

blank

08

Brand Name : Uptravi

Selexipag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Uptravi

arrow
Antibody Engineering
Not Confirmed

Selexipag

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 819

2018 Revenue in Millions : 663

Growth (%) : 24

blank